New Therapies for the Treatment of Spastic Cerebral Palsy
Journal Title: Medical Journal of Clinical Trials & Case Studies - Year 2019, Vol 3, Issue 1
Abstract
Background: Cerebral palsy is a heterogeneous condition associated with a non-progressive lesion, but permanent disorder of movement with limited mobility. It is generally associated with gross motor developmental delay. In moderate to severe cases motor developmental milestones such as walking may never be achieved. There are no specific therapies for cerebral palsy, and treatment of spastic cerebral palsy is generally aiming at improving mobility through muscle relaxation and physiotherapy. This is a retrospective observational study describing the treatment of spastic cerebral palsy with individualized treatment plans providing a new combination of interventions including nutritional support, muscle relaxants and the use of oral pyritinol, intramuscular piracetam, citicoline (oral and injectable), intramuscular cerebrolysin, and intramuscular nandrolone decanoate. Treatment aimed primarily at improving motor development particularly standing and walking. Patients and Methods: During the year 2018, six patients (3 girls and 3 boys) with spastic cerebral palsy and marked motor disability were treated. The patient age ranged from 22 months to three years. All patients were unable to stand or walk, and had poor speech development. Four patients (Patients 1, 4, 5, and 6) had severe cerebral palsy and were even not able to sit. The other two patients had moderately severe disorder and were unable to stand or walk. All the patients were not saying any word or were saying only few words. Results: After treatment, all the patients experienced improvement in motor development without the occurrence of any side effect. Five patients were able to stand with support (patients 1,2,3,4, and 5), and four of them were also able to walk few steps with support. The sixth patient remained unable to stand and the limited benefit of treatment was attributed to some degree of deformity and muscle contracture. In all patients treatment was associated with initiation of speech development or improved speech. It was possible to demonstrate improvement in fine motor skills in three patients (Patient 2, 3, and 5). Conclusion: The treatment of patients with spastic cerebral palsy (moderate and severe) with this individualized treatment plans was associated with a beneficial effect on motor development particularly standing and walking.
Authors and Affiliations
Aamir Jalal Al M*
Keywords
Related Articles
- EP ID EP755855
- DOI 10.23880/mjccs-16000209
- Views 4
- Downloads 0
Use of Abdominal Adipose Tissue for Interposition in Unilateral Temporo-Mandibular Joint Ankylosis - A Case Report
Introduction: Temporo-mandibular ankylosis is a debilitating condition resulting in immobile lower jaw, reduced mouth opening, facial asymmetry and reduced general health status. This article is a case report of post tr...
Medical Information from Internet for Tunisian Cancer Patients: A Double-Edged Weapon?
Background: Most cancer patients and/or their families consult the websites of scientific or patients’ associations to find answers about diagnosis, treatment protocols and side effects, making internet nowadays the eas...
Isolated Hydatid Cyst of Intestine
Hydatid cyst is zoonotic diseases mainly affect liver. Hydatid cyst involving other organ is very rare. Hydatid cyst involving other abdominal organ is mostly due to dissemination or rupture. Isolated involvement other...
Scleromalacia Perforans Secondary to a Pemphigus
Scleromalacia perforans is a rare form of anterior scleritis represented by progressive thinning of the sclera. It is most often associated with rheumatoid arthritis,and sometimes seen in inflammatory systemic disease....
Infants Dermatitis in the Pediatric Unit of Regional Hospital Ebolowa in South Cameroon
Infant dermatitis is one of the reasons of consultation in the pediatric service. It is a real public health problem in Cameroon. The world prevalence of infant dermatitis is around 16% to 37%. In Africa is around 30%...